3:49 PM
 | 
Apr 25, 2019
 |  BC Extra  |  Financial News

BostonGene raises $50M series A to develop personalized cancer therapy software

BostonGene will deploy its $50 million series A funds to scale and develop its cloud-based platform for determining optimal patient-specific cancer therapies.

NEC Corp. is the sole investor in the untranched financing announced on Wednesday.

BostonGene Corp. (Boston,...

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >